网络药理学与分子对接解析青紫止痛汤治疗溃疡性结肠炎机制
研究采用网络药理学与分子对接方法,结合大鼠实验,探讨青紫止痛汤(QZZTD)治疗溃疡性结肠炎(UC)的分子机制。共获得138个共同靶基因,鉴定4个关键活性成分和9个关键蛋白,分子对接显示槲皮素等与8个关键蛋白结合良好,Akt1结合活性最佳。大鼠实验验证QZZTD抑制PI3K-Akt通路激活并减轻炎症。
要点
- QZZTD可能通过槲皮素等4个关键成分作用于Akt1等9个关键蛋白。
- PI3K-Akt、AGE-RAGE、TNF、IL-17通路可能参与QZZTD治疗UC。
- 大鼠实验显示QZZTD抑制PI3K-Akt通路激活并减轻UC炎症。
核心结论
- QZZTD中的槲皮素等4个潜在关键活性成分可与Akt1相互作用并调节PI3K-Akt通路激活。
- 其他三条通路也可能参与QZZTD治疗UC的信号传导。
研究设计与样本
- 研究采用网络药理学与分子对接分析,并辅以大鼠实验验证。
- 从TCMSP数据库获取QZZTD活性成分及靶基因,从GeneCards和OMIM数据库获取UC相关靶基因。
主要发现
- 共获得138个共同靶基因,鉴定出4个关键活性化合物和9个关键蛋白。
- GO和KEGG富集分析显示潜在靶基因的生物学功能与DNA转录、信号受体和配体活性、细胞因子活性、细胞自噬和抗氧化通路相关。
- 相关通路涉及PI3K-Akt信号通路、AGE-RAGE信号通路、TNF信号通路和IL-17信号通路。
- 分子对接显示槲皮素、木犀草素、海罂粟碱和β-谷甾醇与8个关键蛋白结合良好,Akt1结合活性最佳。
- 大鼠实验验证QZZTD抑制PI3K-Akt通路激活并减轻UC炎症。
临床怎么用
- QZZTD可能通过多成分-多靶点-多通路发挥治疗UC的作用,Akt1和PI3K-Akt通路是潜在关键环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ulcerative colitis (UC) is a disease with complex pathological mechanisms. We explored the potential molecular mechanisms behind the therapeutic functions of Qingzi Zhitong decoction (QZZTD) in the treatment of UC by network pharmacology and molecular docking. QZZTD is a formula of Chinese traditional medicine consisting of 10 herbs. The potential active ingredients of QZZTD and their target genes were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform database, and UC-related target genes were obtained from GeneCards and OMIM databases. A total of 138 co-identified target genes were obtained by plotting the intersection target Venn diagram, and then the STRING database and Cytoscape software were used to establish protein-protein interaction networks and herb-ingredient-target networks. Four key active compounds and nine key proteins were identified. Then, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses showed that the biological functions of potential target genes were associated with DNA transcription, signaling receptor and ligand activity, cytokine activity, cellular autophagy, and antioxidant pathways, with related pathways involving the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway, advanced glycosylation end product (AGE)-RAGE signaling pathway, tumor necrosis factor (TNF) signaling pathway, and IL-17 signaling pathway. Moreover, the binding activities of key target genes and essential active compounds of Chinese herbal medicines in QZZTD were further validated by molecular docking. This demonstrated that quercetin, luteolin, hyndarin, and beta-sitosterol had good binding to eight key proteins, and Akt1 was the target protein with the best binding activity, suggesting that Akt1 could be the essential mediator responsible for signaling transduction after QZZTD administration. The rat experiment verified that QZZTD inhibited PI3K-Akt pathway activation and reduced inflammation in UC. In conclusion, our study suggested four potential key active components, including quercetin, were identified in QZZTD, which could interact with Akt1 and modulate the activation of the PI3K-Akt pathway. The other three pathways may also be involved in the signaling transduction induced by QZZTD in the treatment of UC.
引用
- Shou X, Wang Y, Zhang X, et al. Network Pharmacology and Molecular Docking Analysis on Molecular Mechanism of Qingzi Zhitong Decoction in the Treatment of Ulcerative Colitis. Front Pharmacol. 2022. PMID: 35237152. doi:10.3389/fphar.2022.727608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。